|
Diabetes Mellitus, Insulin-Dependent
|
0.130 |
Biomarker
|
disease |
BEFREE |
There were no differences in plasma levels of apoM and S1P between controls and T1D patients, but the apoM/S1P complexes were shifted from dense to light HDL particles in T1D.
|
28385702 |
2017 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
These findings suggest that the functional single-nucleotide polymorphism APOM rs805297 G/T variant allele was associated with RA risk.
|
23660425 |
2014 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Recently, apoM polymorphisms have been related with RA susceptibility.
|
23190940 |
2013 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.130 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein M can discriminate HNF1A-MODY from Type 1 diabetes.
|
23157689 |
2013 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
GWASCAT |
Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis.
|
21844665 |
2011 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
GWASDB |
Common variants at the promoter region of the APOM confer a risk of rheumatoid arthritis.
|
21844665 |
2011 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
Through GWAS, we identified a novel SNP associated with RA at the APOM gene in the MHC class III region on 6p21.33 (rs805297, odds ratio (OR) = 2.28, P = 5.20 × 10-7).
|
21844665 |
2011 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.
|
21156761 |
2011 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we investigate the potential association between the ApoM promoter polymorphisms and type 1 diabetes.
|
19007767 |
2009 |
|
Rheumatoid Arthritis
|
0.130 |
GeneticVariation
|
disease |
GWASDB |
TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.
|
17804836 |
2007 |
|
Diabetes Mellitus, Insulin-Dependent
|
0.130 |
GeneticVariation
|
disease |
GWASDB |
A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene.
|
17632545 |
2007 |
|
Lupus Erythematosus, Systemic
|
0.120 |
Biomarker
|
disease |
BEFREE |
Plasma concentrations of apoM were measured by ELISA in two patient groups with systemic lupus erythematosus (SLE) and in 79 healthy control individuals.
|
31046824 |
2019 |
|
Lupus Erythematosus, Systemic
|
0.120 |
Biomarker
|
disease |
BEFREE |
No association between APOM and SLE susceptibility was detected in our Han Chinese cohort.
|
28476116 |
2017 |
|
Lupus Erythematosus, Systemic
|
0.120 |
GeneticVariation
|
disease |
GWASDB |
GWAS identifies novel SLE susceptibility genes and explains the association of the HLA region.
|
24871463 |
2014 |
|
Malignant neoplasm of lung
|
0.110 |
Biomarker
|
disease |
BEFREE |
Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1/2 and PI3K/AKT signaling pathways.
|
29750961 |
2018 |
|
Malignant neoplasm of lung
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls.
|
22899653 |
2012 |
|
Malignant neoplasm of lung
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study.
|
19654303 |
2009 |
|
Malignant neoplasm of lung
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Common 5p15.33 and 6p21.33 variants influence lung cancer risk.
|
18978787 |
2008 |
|
Diabetes Mellitus, Non-Insulin-Dependent
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Obesity, metabolic syndrome and type 2 diabetes are associated with low circulating ApoM and adipose tissue APOM expression.
|
31815756 |
2020 |
|
Arteriosclerosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The axis of apolipoprotein M (apoM) and sphingosine-1-phosphate (S1P) is of importance to plasma lipid levels, endothelial function, and development of atherosclerosis.
|
30433864 |
2019 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In spite of the important role of Apolipoprotein-M (ApoM) and Sphingosine-1-Phosphate (S1P) played in atherosclerosis (AS), there was few related research reporting ApoM and S1P complex (ApoM-S1P) on biological activities of human umbilical vein endothelial cells (HUVECs).
|
31791242 |
2019 |
|
Arteriosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
To clarify what role apoM plays in atherosclerosis, we used oxidized low-density lipoprotein (ox-LDL) to induce an inflammatory model of atherosclerosis.
|
30377890 |
2019 |
|
Atherosclerosis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
The axis of apolipoprotein M (apoM) and sphingosine-1-phosphate (S1P) is of importance to plasma lipid levels, endothelial function, and development of atherosclerosis.
|
30433864 |
2019 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
In spite of the important role of Apolipoprotein-M (ApoM) and Sphingosine-1-Phosphate (S1P) played in atherosclerosis (AS), there was few related research reporting ApoM and S1P complex (ApoM-S1P) on biological activities of human umbilical vein endothelial cells (HUVECs).
|
31791242 |
2019 |
|
Atherosclerosis
|
0.100 |
Biomarker
|
disease |
BEFREE |
To clarify what role apoM plays in atherosclerosis, we used oxidized low-density lipoprotein (ox-LDL) to induce an inflammatory model of atherosclerosis.
|
30377890 |
2019 |